Biogenesis of Lp(a) in transgenic mouse hepatocytes

Clinical Genetics

Volumn 52, Issue 5, 1997, Pages 326-337

  White, Ann L ^a,b  

^a SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Apo(a) folding; Apo(a) secretion; Apo(a) synthesis; Lp(a) assembly; Primary hepatocyte cultures; Transgenic mice

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; DISULFIDE; LIPOPROTEIN A;

ANIMAL CELL; BIOGENESIS; CELL SURFACE; CONFERENCE PAPER; CONTROLLED STUDY; CULTURE MEDIUM; ENDOPLASMIC RETICULUM; KRINGLE DOMAIN; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LIVER CELL CULTURE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0031426345     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1997.tb04350.x     Document Type: Conference Paper

References (81)

1. Allen S, Naim HY, Bulleid NJ. Intracellular folding of tissue-type plasminogen activator. Effects of disulfide bond formation on N-linked glycosylation and secretion. J Biol Chem 1995: 270: 4797-4804.
2. Azrolan N, Gavish D, Breslow JL. Plasma lipoprotein(a) concentration is controlled by apolipoprotein(a) (apo(a)) protein size and the abundance of hepatic apo(a) mRNA in a cynomolgus monkey model. J Biol Chem 1991: 266: 13866-13872.
3. Berg K. A new serum type system in man - Lp system. Acta Pathol Microbiol Scand 1963: 59: 369-382.
4. Berg K, Kondo I, Drayna D, Lawn R. Restriction site polymorphism at the LPA (Lp(a) apolipoprotein; apolipoprotein(a)) locus. Clin Genet 1990: 37: 473-480.
5. Boerwinkle E, Leffert CC, Lin J, Lackner C, Chiesa G, Hobbs HH. Apoliproprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest 1992: 90: 52-60.
6. Bonen DK, Hausman AML, Hadjiagapiou C, Skarosi SF, Davidson NO. Expression of a recombinant apoliproprotein(a) in HepG2 cells. Evidence for intracellular assembly of lipoprotein(a). J Biol Chem 1997: 272: 5659-5667.
7. Bopp S, Kochl S, Acquati F, Magnaghi P, Petho-Schramm A, Kraft HG, Utermann G, Muller HJ, Taramelli R. Ten allelic apolipoprotein(a) 5′ flanking fragments exhibit comparable promoter activities in HepG2 cells. J Lipid Res 1995: 36: 1721-1728.
8. Borchardt RA, Davis RA. Intrahepatic assembly of very low density lipoproteins. Rate of transport out of the endoplasmic reticulum determines rate of secretion. J Biol Chem 1987: 262: 16394-16402.
9. Braakman I, Helenius J, Helenius A. Manipulating disulfide bond formation and protein folding in the endoplasmic reticulum. EMBO J 1992 11: 1717-1722.
10. Brunner C, Lobentanz EM, Petho-Schramm A, Ernst A, Kang C, Dieplinger H, Miller HJ, Utermann G. The number of identical kringle IV repeats in apolipoprotein(a) affects its processing and secretion by HepG2 cells. J Biol Chem 1996: 271: 32403-32410.
11. Callow MJ, Rubin EM. Site-specific mutagenesis demonstrates that cysteine 4326 of apolipoprotein B is required for covalent linkage with apolipoprotein(a) in vivo. J Biol Chem 1995: 270: 23914-23917.
12. Callow MJ, Stoltzfus LJ, Lawn RM, Rubin EM. Expression of human apolipoprotein B and assembly of lipoprotein(a) in transgenic mice. Proc Natl Acad Sci USA 1994: 91, 2130-2134.
13. Callow MJ, Verstuyft J, Tangirala R, Palinski W, Rubin EM. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein(a). J Clin Invest 1995: 96: 1639-1646.
14. Chiesa G, Hobbs HH, Koschinsky ML, Lawn RM, Maika SD, Hammer RE. Reconstitution of lipoprotein(a) by infusion of human low density lipoprotein into transgenic mice expressing human apolipoprotein(a). J Biol Chem 1992: 267: 24369-24374.
15. Cohen JC, Chiesa G, Hobbs HH. Sequence polymorphisms in the apolipoprotein(a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels. J Clin Invest 1993: 91: 1630-1636.
16. Duvic CR, Smith G, Sledge WE, Lee LT, Murray MD, Roheim PS, Gallaher WR, Thompson JJ. Identification of a mouse monoclonal antibody, LHLP-1, specific for human Lp(a). J Lipid Res 1985: 26: 540-548.
17. Edelstein C, Mandala M, Pfaffinger D, Scanu AM. Determinants of lipoprotein(a) assembly: a study of wild-type and mutant apolipoprotein(a) phenotypes isolated from human and rhesus monkey lipoprotein(a) under mild reductive conditions. Biochemistry 1995: 34: 16483-16492.
18. Ernst A, Helmhold M, Brunner C, Pethö-Schramm A, Armstrong VW, Miller H-J. Identification of two functionally distinct lysine-binding sites in kringle 37 and in kringles 32-36 of human apolipoprotein(a). J Biol Chem 1995: 270: 6227-6234.
19. Fless GM, Snyder ML, Scanu AM. Enzyme-linked immunoassay for Lp(a). J Lipid Res 1989: 30: 651-662.
20. Frank S, Krasznai K, Durovic S, Lobentanz E.-M, Dieplinger H, Wagner E, Zatloukal K, Cotten M, Utermann G, Kostner GM, Zechner R. High-level expression of various apolipoprotein(a) isoforms by "transferrinfection": The role of kringle IV sequences in the extracellular association with low-density lipoprotein. Biochemistry 1994: 33: 12329-12339.
21. Frazer KA, Narla G, Zhang JL, Rubin EM. The apolipoprotein(a) gene is regulated by sex hormones and acute-phase inducers in YAC transgenic mice. Nat Genet 1995: 9: 424-431.
22. Gabel B, Yao Z, McLeod RS, Young SG, Koschinsky ML. Carboxyl-terminal truncation of apolipoprotein B-100 inhibits lipoprotein(a) particle formation. FEBS Lett 1994: 350: 77-81.
23. Gaubatz JW, Cushing GL, Morrisett JD. Quantitation, isolation, and characterization of human lipoprotein(a). Meth Enzymol 1986: 129: 167-186.
24. Gaubatz JW, Ghanem KI, Guevara J, Jr, Nava ML, Patsch W, Morrisett JD. Polymorphic forms of human apolipoprotein(a): inheritance and relationship of their molecular weights to plasma levels of lipoprotein(a). J Lipid Res 1990: 31: 603-613.
25. Gaubatz JW, Heideman C, Gotto AM, Jr, Morrisett JD, Dahlen GH. Human plasma lipoprotein(a) structural properties. J Biol Chem 1983: 258: 4582-4589.
26. Gething M-J. & Sambrook J. Protein folding in the cell. Nature 1992: 355: 33-45.
27. Grainger DJ, Kemp PR, Liu AC, Lawn RM, Metcalfe JC. Activation of transforming growth factor-β is inhibited in transgenic apolipoprotein(a) mice. Nature 1994: 370: 460-462.
28. Hixson JE, Britten ML, Manis GS, Rainwater DL. Apolipoprotein(a) (apo(a)) glycoprotein isoforms result from size differences in apo(a) mRNA in baboons. J Biol Chem 1989: 264: 6013-6016.
29. Hughes SD, Rouy D, Navaratnam N, Scott J, Rubin EM. Gene transfer of cytidine deaminase apoBEC-1 lowers lipoprotein(a) in transgenic mice and induces apolipoprotein B editing in rabbits. Hum Gene Ther 1996: 7: 39-49.
30. Ichinose A. Multiple members of the plasminogen-apolipoprotein(a) gene family associated with thrombosis. Biochemistry 1992: 31: 3113-3118.
31. Ichinose A, Kuriyama M. Detection of polymorphisms in the 5′-flanking region of the gene for apolipoprotein(a). Biochem Biophys Res Commun 1995: 209: 372-378.
32. Keesler GA, Li Y, Skiba PJ, Fless GM, Tabas I. Macrophage foam cell lipoprotein(a) apolipoprotein(a) receptor: cell-surface localization, dependence of induction on new protein synthesis, and ligand specificity. Arterioscler Thromb 1994: 14: 1337-1345.
33. Kim PS, Arvan P. Calnexin and BiP act as sequential molecular chaperones during thyroglobulin folding in the endoplasmic reticulum. J Cell Biol 1995: 128: 29-38.
34. Koschinsky ML, Côté GP, Gabel B, Van der Hoek YY. Identification of the cysteine residue in apolipoprotein(a) that mediates extracellular coupling with apolipoprotein B-100. J Biol Chem 1993: 268: 19819-19825.
35. Koschinsky ML, Tomlinson JE, Zioncheck TF, Schwartz K, Eaton DL, Lawn RM. Apolipoprotein(a): expression and characterization of a recombinant form of the protein in mammalian cells. Biochemistry 1991: 30: 5044-5051.
36. Kraft HG, Haibach C, Lingenhel A, Brunner C, Trommsdorff M, Kronenberg F, Müller HJ, Utermann G. Sequence polymorphism in kringle IV 37 in linkage disequilibrium with the apolipoprotein(a) size polymorphism. Hum Genet 1995: 95: 275-282.
37. Kraft HG, Menzel HJ, Hoppichler F, Vogel W, Utermann G. Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest 1989: 83: 137-142.
38. Krempler F, Kostner GM, Bolzano K Turnover of lipoprotein(a) in man. J Clin Invest 1980: 65: 1483-1490.
39. Lackner C, Cohen JC, Hobbs HH. Molecular definition of the extreme size polymorphism in apolipoprotein(a). Hum Mol Genet 1993: 2: 933-940.
40. Lanford RE, Carey KD, Estlack LE, Smith GC, Hay RV. Analysis of plasma protein and lipoprotein synthesis in long-term primary cultures of baboon hepatocytes maintained in serum-free medium. In Vitro Cell Dev Biol 1989: 25: 174-182.
41. Lanford RE, Estlack L, White AL. Neomycin inhibits secretion of apolipoprotein(a) by increasing retention on the hepatocyte cell surface. J Lipid Res 1996: 37: 2055-2064.
42. Laplaud PM, Beaubatie L, Rall SC, Jr, Luc G, Saboureau M. Lipoprotein(a) is the major apoB-containing lipoprotein in the plasma of a hibernator, the hedgehog (Erinaceus europaeus). J Lipid Res 1988: 29: 1157-1170.
43. Lawn RM, Boonmark NW, Schwartz K, Lindahl GE, Wade DP, Byrne CD, Fong KJ, Meer K, Patthy L. The recurring evolution of lipoprotein(a) - insights from cloning of hedgehog apolipoprotein(a). J Biol Chem 1995: 270: 24004-24009.
44. Lawn RM, Wade DP, Hammer RE, Chiesa G, Verstuyft JG, Rubin EM. Atherogenesis in transgenic mice expressing human apolipoprotein(a). Nature 1992: 360: 670-672.
45. Linton MF, Farese RV, Jr, Chiesa G, Grass DS, Chin P, Hammer RE, Hobbs HH, Young SG. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J Clin Invest 1993: 92: 3029-3037.
46. Liu AC, Lawn RM, Verstuyft JG, Rubin EM. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein(a) in transgenic mice. J Lipid Res 1994: 35: 2263-2267.
47. Makino K, Scanu AM. Lipoprotein(a): nonhuman primate models. Lipids 1991: 26: 679-683.
48. Mancini FP, Mooser V, Guerra R, Hobbs HH. Sequence microheterogeneity in apolipoprotein(a) gene repeats and the relationship to plasma Lp(a) levels. Hum Mol Genet 1995a: 4: 1535-1542.
49. Mancini FP, Newland DL, Mooser V, Murata J, Marcovina S, Young SG, Hammer RE, Sanan DA, Hobbs HH. Relative contributions of apolipoprotein(a) and apolipoprotein-B to the development of fatty lesions in the proximal aorta of mice. Arterioscler Thromb Vasc Biol 1995b: 15: 1911-1916.
50. Marcovina SM, Zhang ZH, Gaur VP, Albers JJ. Identification of 34 apolipoprotein(a) isoforms: differential expression of apolipoprotein(a) alleles between American Blacks and Whites. Biochem Biophys Res Commun 1993: 191: 1192-1196.
51. McCormick SPA, Linton MF, Hobbs HH, Taylor S, Curtiss LK, Young SG. Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein(a). J Biol Chem 1994: 269: 24284-24289.
52. McCormick SPA, Ng JK, Taylor S, Flynn LM, Hammer RE, Young SG. Mutagenesis of the human apolipoprotein B gene in a yeast artificial chromosome reveals the site of attachment for apolipoprotein(a). Proc Natl Acad Sci USA 1995: 92: 10147-10151.
53. McLean JW, Tomlinson JE, Kuang W, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987: 330: 132-137.
54. Mooser V, Mancini FP, Bopp S, Pethö-Schramm A, Guerra, R, Boerwinkle E, Müller, H.-J., Hobbs, HH. Sequence polymorphisms in the apo(a) gene associated with specific levels of Lp(a) in plasma. Hum Mol Genet 1995: 4: 173-181.
55. Palabrica TM, Liu AC, Aronovitz MJ, Furie B, Lawn RM, Furie BC. Antifibrinolytic activity of apolipoprotein(a) in vivo: human apolipoprotein(a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nat Med 1995: 1: 256-259.
56. Rader DJ, Cain W, Ikewaki K, Talley G, Zech LA, Usher D, Brewer HB, Jr. The inverse association of plasma lipoprotein(a) concentrations with apolipoprotein(a) isoform size is not due to differences in Lp(a) catabolism but to differences in production rate. J Clin Invest 1994: 93: 2758-2763.
57. Rader DJ, Cain W, Zech LA, Usher D, Brewer HB, Jr. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein(a) isoform is determined by the rate of lipoprotein(a) production. J Clin Invest 1993: 91: 443-447.
58. Rainwater DL, Lanford RE. Production of lipoprotein(a) by primary hepatocytes. Biochim Biophys Acta 1989: 1003: 30-35.
59. Rainwater DL, Manis GS. Immunochemical characterization and quantitation of lipoprotein(a)in baboons. Atherosclerosis 1988: 73: 23-31.
60. Rainwater DL, Manis GS, VandeBerg JL. Hereditary and dietary effects on apolipoprotein(a) isoforms and Lp(a) in baboons. J Lipid Res 1989: 30: 549-558.
61. Rubin EM. Studies of lipoprotein(a) and high density lipoproteins in transgenic mice. Atherosclerosis 1994: 110 Suppl. S77-S81.
62. Scanu AM, Fless GM. Lipoprotein(a). Heterogeneity and biological relevance. J Clin Invest 1990: 85: 1709-1715.
63. 37. J Clin Invest 1993: 91: 283-291.
64. Scanu, AM, Pfaffinger D, Lee JC, Hinman J A single point mutation (Trp72→Arg) in human apo(a) kringle 4-37 associated with a lysine binding defect in Lp(a). Biochim Biophys Acta Mol Basis Dis 1994: 1227: 41-45.
65. Seglen PO. Preparation of isolated rat liver cells. Methods in Cell Biology 1976: 13: 29-81.
66. Sparks JD, Sparks CE. Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes. J Biol Chem 1987: 265: 8854-8862.
67. Suzuki K, Kuriyama M, Saito T, Ichinose A. Plasma lipoprotein(a) levels and expression of the apolipoprotein(a) gene are dependent on the nucleotide polymorphisms in its 5′-flanking region. J Clin Invest 1997: 99: 1361-1366.
68. Thrift RN, Forte TM, Cahoon BE, Shore VG. Characterization of lipoproteins produced by the human liver cell line, HepG2, under denned conditions. J Lipid Res 1986: 27: 236-250.
69. Tomlinson JE, McLean JW, Lawn RM. Rhesus monkey apolipoprotein(a). Sequence, evolution, and sites of synthesis. J Biol Chem 1989: 264: 5957-5965.
70. Trieu VN, McConathy WJ. A two-step model for lipoprotein(a) formation. J Biol Chem 1995: 270: 15471-15474.
71. 3304-3317 peptide as an inhibitor of the lipoprotein(a): apolipoprotein B-containing lipoprotein interaction. Biochem J 1995: 307: 17-22.
72. Utermann G. The mysteries of lipoprotein(a). Science 1989: 246: 904-910.
73. Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C. Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest 1987: 80: 458-465.
74. Wade DP, Clarke JG, Lindahl GE, Liu AC, Zysow BR, Meer K, Schwartz K, Lawn RM. 5′ control regions of the apolipoprotein(a) gene and members of the related plasminogen gene family. Proc Natl Acad Sci USA 1993: 90: 1369-1373.
75. White AL, Graham DL, LeGros J, Pease RJ, Scott J. Oleate-mediated stimulation of apolipoprotein B secretion from rat hepatoma cells. A function of the ability of apolipoprotein B to direct lipoprotein assembly and escape presecretory degradation. J Biol Chem 1992: 267: 15657-15664.
76. White AL, Guerra B, Lanford RE. Influence of allelic variation on apolipoprotein(a) folding in the endoplasmic reticulum. J Biol Chem 1997: 272: 5048-5055.
77. White AL, Hixson JE, Rainwater DL, Lanford RE. Molecular basis for "null" lipoprotein(a) phenotypes and the influence of apolipoprotein(a) size on plasma lipoprotein(a) level in the baboon. J Biol Chem 1994a: 269: 9060-9066.
78. White AL, Lanford RE. Cell surface assembly of lipoprotein(a) in primary cultures of baboon hepatocytes. J Biol Chem 1994: 269: 28716-28723.
79. White AL, Rainwater DL, Hixson JE, Estlack LE, Lanford RE. Intracellular processing of apo(a) in primary baboon hepatocytes. Chem Phys Lipids 1994b 67-68, 123-133.
80. White AL, Rainwater DL, Lanford RE. Intracellular maturation of apolipoprotein(a) and assembly of lipoprotein(a) in primary baboon hepatocytes. J Lipid Res 1993: 34: 509-517.
81. Zysow BR, Lindahl GE, Wade DP, Knight BL, Lawn RM. C/T polymorphism in the 5′ untranslated region of the apolipoprotein(a) gene introduces an upstream ATG and reduces in vitro translation. Arterioscler Thromb 1995: 15: 58-64.